133 results
Page 2 of 7
S-3ASR
EX-4.2
auvctk21oek 13z
15 Sep 21
Automatic shelf registration
4:16pm
8-K
EX-99.1
z8q1v5gll
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.1
edrt1f34tv9r02oql
3 Aug 21
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021
4:08pm
8-K
EX-10.1
gol9iex3kwp4
23 Apr 21
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-4.1
iv6w3r6h62jmo09xx6
8 Apr 21
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.2
p1380g0
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K
EX-10.1
1vhpugte3 h759ykty
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K/A
EX-99.4
3l7zonaebca3535i6e9
5 Apr 21
Financial Statements and Exhibits
4:11pm
S-3ASR
EX-4.2
p53qircucfvv
26 Feb 21
Automatic shelf registration
12:00am
424B5
whpzs6e5s4u574hsgmc5
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
fm86l
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
pfn4cgu9id2m
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K/A
EX-99.3
eid4cvgown51zqc
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.1
o26usrf2uoq90
23 Nov 20
Consolidated Financial Statements
12:00am